Markets › United States › NAS › DTIL

Precision BioSciences Inc

NAS:DTILHealthcareCBOEFTSE:MRUTNASDAQ:NCX

$6.73−0.74%LiveIn session · ≈ AED 24.72 · Market cap $185.76M · Next earnings Mon 2 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	—	—
Operating margin	−452.2%	−34.1%	−248.3%	−89.8%	−38.1%	−152.2%	−152.2%	+0.0 pts
Net margin	−448.9%	−26.5%	−444.8%	−125.8%	10.4%	−133.4%	−133.4%	+0.0 pts
EBITDA margin	−408.5%	−17.5%	−250.2%	−65.8%	19.7%	−123.8%	—	—
Return on equity	−245.4%	−33.6%	−184.7%	−325.1%	12.7%	−49.6%	−49.6%	+0.0 pts
Return on assets	−72.6%	−14.5%	−46.9%	−38.4%	5.3%	−29.6%	−29.6%	+0.0 pts
Return on capital employed	−102.3%	−22.4%	−34.9%	−39.8%	−21.5%	−35.8%	—	—
Debt / equity	0.2×	0.1×	0.4×	1.7×	0.5×	0.3×	0.3×	+0.0%
Debt / assets	7.0%	4.3%	10.5%	19.6%	22.0%	18.7%	—	—
Interest coverage	0.0×	−298.3×	−56.1×	−19.6×	−14.7×	−36.7×	—	—
Current ratio	2.5×	4.5×	3.3×	2.7×	6.3×	13.3×	13.3×	+0.0%
Quick ratio	2.5×	4.5×	3.3×	2.7×	6.3×	13.3×	—	—
Cash ratio	2.1×	4.0×	3.2×	2.3×	5.7×	12.4×	12.4×	+0.0%
Asset turnover	0.2×	0.5×	0.1×	0.3×	0.5×	0.2×	—	—
Receivables turnover	2.4×	236.7×	34.9×	3.8×	40.5×	—	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—